Aurobindo Pharma reported INR91.5B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Cipla INR 71.19B 5.78B Jun/2026
Divis Laboratories Ltd INR 27.58B 730M Jun/2026
Dr.Reddys Laboratories INR 80.71B 5.25B Jun/2026
Hindustan Unilever INR 168.9B 8.94B Jun/2026
Sun Pharmaceuticals INR 153B 7.14B Jun/2026
UPL INR 101.81B 81.54B Jun/2026